187 related articles for article (PubMed ID: 35064767)
21. Metformin is a potent inhibitor of endometrial cancer cell proliferation--implications for a novel treatment strategy.
Cantrell LA; Zhou C; Mendivil A; Malloy KM; Gehrig PA; Bae-Jump VL
Gynecol Oncol; 2010 Jan; 116(1):92-8. PubMed ID: 19822355
[TBL] [Abstract][Full Text] [Related]
22. KIFC1 promotes aerobic glycolysis in endometrial cancer cells by regulating the c-myc pathway.
Zhou K; Lin J; Dai M; He Y; Xu J; Lin Q
J Bioenerg Biomembr; 2021 Dec; 53(6):703-713. PubMed ID: 34729671
[TBL] [Abstract][Full Text] [Related]
23. Metformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and modulation of the mTOR pathway.
Hanna RK; Zhou C; Malloy KM; Sun L; Zhong Y; Gehrig PA; Bae-Jump VL
Gynecol Oncol; 2012 May; 125(2):458-69. PubMed ID: 22252099
[TBL] [Abstract][Full Text] [Related]
24. [Preliminary investigation of the expression and functions of insulin receptor isoforms in endometrial carcinoma].
Zhang G; Li XP; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):839-45. PubMed ID: 23302125
[TBL] [Abstract][Full Text] [Related]
25. Metformin down-regulates endometrial carcinoma cell secretion of IGF-1 and expression of IGF-1R.
Zhang Y; Li MX; Wang H; Zeng Z; Li XM
Asian Pac J Cancer Prev; 2015; 16(1):221-5. PubMed ID: 25640355
[TBL] [Abstract][Full Text] [Related]
26. Jupiter microtubule-associated homolog 1 (JPT1): A predictive and pharmacodynamic biomarker of metformin response in endometrial cancers.
Bateman NW; Teng PN; Hope E; Hood BL; Oliver J; Ao W; Zhou M; Wang G; Tommarello D; Wilson K; Litzy T; Conrads KA; Hamilton CA; Darcy KM; Casablanca Y; Maxwell GL; Bae-Jump V; Conrads TP
Cancer Med; 2020 Feb; 9(3):1092-1103. PubMed ID: 31808620
[TBL] [Abstract][Full Text] [Related]
27. Metformin targeting autophagy overcomes progesterone resistance in endometrial carcinoma.
Zhuo Z; Wang A; Yu H
Arch Gynecol Obstet; 2016 Nov; 294(5):1055-1061. PubMed ID: 27402506
[TBL] [Abstract][Full Text] [Related]
28. Metformin regulation of progesterone receptor isoform-B expression in human endometrial cancer cells is glucose-dependent.
Saguyod SJU; Alhallak I; Simmen RCM; Velarde MC
Oncol Lett; 2020 Nov; 20(5):249. PubMed ID: 32994812
[TBL] [Abstract][Full Text] [Related]
29. Combination simvastatin and metformin synergistically inhibits endometrial cancer cell growth.
Kim JS; Turbov J; Rosales R; Thaete LG; Rodriguez GC
Gynecol Oncol; 2019 Aug; 154(2):432-440. PubMed ID: 31178149
[TBL] [Abstract][Full Text] [Related]
30. Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer.
Schuler KM; Rambally BS; DiFurio MJ; Sampey BP; Gehrig PA; Makowski L; Bae-Jump VL
Cancer Med; 2015 Feb; 4(2):161-73. PubMed ID: 25417601
[TBL] [Abstract][Full Text] [Related]
31. Roles of estrogen receptor α and β in the regulation of proliferation in endometrial carcinoma.
Hu G; Zhang J; Zhou X; Liu J; Wang Q; Zhang B
Pathol Res Pract; 2020 Oct; 216(10):153149. PubMed ID: 32853964
[TBL] [Abstract][Full Text] [Related]
32. Effects of Metformin on Cellular Proliferation and Steroid Hormone Receptors in Patient-Derived, Low-Grade Endometrial Cancer Cell Lines.
Collins G; Mesiano S; DiFeo A
Reprod Sci; 2019 May; 26(5):609-618. PubMed ID: 29848180
[TBL] [Abstract][Full Text] [Related]
33. [Effects of metformin and adiponectin on endometrial cancer cells growth].
Wang XH; Zhang Y; Liu LZ; Shang CG
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Oct; 50(5):767-773. PubMed ID: 30337733
[TBL] [Abstract][Full Text] [Related]
34. Metformin reverses progestin resistance in endometrial cancer cells by downregulating GloI expression.
Zhang Z; Dong L; Sui L; Yang Y; Liu X; Yu Y; Zhu Y; Feng Y
Int J Gynecol Cancer; 2011 Feb; 21(2):213-21. PubMed ID: 21270604
[TBL] [Abstract][Full Text] [Related]
35. The role of adipose-derived stem cells in endometrial cancer proliferation.
Linkov F; Kokai L; Edwards R; Sheikh MA; Freese KE; Marra KG; Rubin JP
Scand J Clin Lab Invest Suppl; 2014; 244():54-8; discussion 57-8. PubMed ID: 25083894
[TBL] [Abstract][Full Text] [Related]
36. A Novel Metabolic Reprogramming Strategy for the Treatment of Diabetes-Associated Breast Cancer.
Hao Q; Huang Z; Li Q; Liu D; Wang P; Wang K; Li J; Cao W; Deng W; Wu K; Su R; Liu Z; Vadgama J; Wu Y
Adv Sci (Weinh); 2022 Feb; 9(6):e2102303. PubMed ID: 35023320
[TBL] [Abstract][Full Text] [Related]
37. Induction of Apoptosis in Endometrial Cancer (Ishikawa) Cells by Pogostemon cablin Aqueous Extract (PCAE).
Tsai CC; Chang YH; Chang CC; Cheng YM; Ou YC; Chien CC; Hsu YC
Int J Mol Sci; 2015 Jun; 16(6):12424-35. PubMed ID: 26042464
[TBL] [Abstract][Full Text] [Related]
38. Effect of Metformin For Decreasing Proliferative Marker in Women with Endometrial Cancer: A Randomized Double-blind Placebo-Controlled Trial.
Petchsila K; Prueksaritanond N; Insin P; Yanaranop M; Chotikawichean N
Asian Pac J Cancer Prev; 2020 Mar; 21(3):733-741. PubMed ID: 32212801
[TBL] [Abstract][Full Text] [Related]
39. High Glucose Promotes Epithelial-Mesenchymal Transition of Uterus Endometrial Cancer Cells by Increasing ER/GLUT4-Mediated VEGF Secretion.
Gu CJ; Xie F; Zhang B; Yang HL; Cheng J; He YY; Zhu XY; Li DJ; Li MQ
Cell Physiol Biochem; 2018; 50(2):706-720. PubMed ID: 30308493
[TBL] [Abstract][Full Text] [Related]
40. Progesterone induces cell apoptosis via the CACNA2D3/Ca2+/p38 MAPK pathway in endometrial cancer.
Kong X; Li M; Shao K; Yang Y; Wang Q; Cai M
Oncol Rep; 2020 Jan; 43(1):121-132. PubMed ID: 31746409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
